These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17458257)

  • 1. [Pathophysiology and management of impaired glucose tolerance and diabetes with metabolic syndrome].
    Ohara T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():428-32. PubMed ID: 17458257
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.
    Tam WH; Ma RC; Yang X; Ko GT; Tong PC; Cockram CS; Sahota DS; Rogers MS; Chan JC
    Pediatrics; 2008 Dec; 122(6):1229-34. PubMed ID: 19047239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exercise and diet as targeted treatments of metabolic syndrome].
    Uusitupa M
    Duodecim; 2001; 117(6):621-30. PubMed ID: 12116497
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
    Bourn DM
    Diabet Med; 1996 Nov; 13(11):938-45. PubMed ID: 8946151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of prediabetes.
    Bhansali A; Dutta P
    J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
    Deedwania PC; Fonseca VA
    Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exercise therapy for obese impaired glucose tolerance patients].
    Sakamoto S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():517-20. PubMed ID: 15779433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impaired glucose tolerance (IGT): current understanding and future research directions].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():21-6. PubMed ID: 15779340
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
    Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of impaired glucose tolerance: physical training therapy].
    Sato Y; Sato J; Tokudome S
    Nihon Rinsho; 1996 Oct; 54(10):2745-9. PubMed ID: 8914438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a single vs multiple bouts of exercise on glucose control in women with type 2 diabetes.
    Baynard T; Franklin RM; Goulopoulou S; Carhart R; Kanaley JA
    Metabolism; 2005 Aug; 54(8):989-94. PubMed ID: 16092046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of the brain for the regulation of energy and glucose metabolism].
    Rother E; Jordan SD; Brüning JC
    Dtsch Med Wochenschr; 2009 May; 134(20):1057-9. PubMed ID: 19421928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetic campaign in Toyama: framework and program for organized cooperation in regional diabetes care and prevention].
    Fujikawa M; Kano B; Shiiba S; Kobayashi M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():565-77. PubMed ID: 15779442
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiological conditions progressing from impaired glucose tolerance: atherosclerosis].
    Yokote K; Saito Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():250-4. PubMed ID: 15779381
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis.
    Tkác I
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S2-9. PubMed ID: 15955370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.